lisofylline has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelzaher, LA; Ali, M; Bakr, MH; Desai, AA; Mali, V; Radwan, E; Sayed, SA | 1 |
| Bevard, MH; Chakrabarti, SK; Cole, BK; Dobrian, AD; Gu, J; Keller, SR; Ma, Q; Nadler, JL; Pei, H; Vandenhoff, GE; Wen, Y; Williams, MD | 1 |
2 other study(ies) available for lisofylline and Obesity
| Article | Year |
|---|---|
Lisofylline mitigates cardiac inflammation in a mouse model of obesity through improving insulin secretion and activating cardiac AMPK signaling pathway.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Glucose; Body Weight; Disease Models, Animal; Heart; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Myocardium; Obesity; Pentoxifylline; Signal Transduction; Up-Regulation | 2021 |
Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.
Topics: 3T3-L1 Cells; 5-Lipoxygenase-Activating Proteins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 12-Lipoxygenase; Arachidonate 5-Lipoxygenase; Arachidonic Acids; Cytokines; Female; Gene Expression Regulation; Inflammation Mediators; Intra-Abdominal Fat; Mice; Obesity; Pentoxifylline; Phosphorylation; Rats; Rats, Zucker; RNA, Messenger; STAT4 Transcription Factor | 2011 |